Literature DB >> 19259824

Embryonal neural tumours and cell death.

John Inge Johnsen1, Per Kogner, Ami Albihn, Marie Arsenian Henriksson.   

Abstract

Medulloblastoma and neuroblastoma are malignant embryonal childhood tumours of the central and peripheral nervous systems, respectively, which often show poor clinical prognosis due to resistance to current chemotherapy. Both these tumours have deficient apoptotic machineries adopted from their respective progenitor cells. This review focuses on the specific background for tumour development, and highlights biological pathways that present potential targets for novel therapeutic approaches.

Entities:  

Mesh:

Year:  2009        PMID: 19259824     DOI: 10.1007/s10495-009-0325-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  18 in total

1.  Rho-associated kinase is a therapeutic target in neuroblastoma.

Authors:  Cecilia Dyberg; Susanne Fransson; Teodora Andonova; Baldur Sveinbjörnsson; Jessika Lännerholm-Palm; Thale K Olsen; David Forsberg; Eric Herlenius; Tommy Martinsson; Bertha Brodin; Per Kogner; John Inge Johnsen; Malin Wickström
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 2.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 3.  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

Authors:  Cecilia Söderberg-Nauclér; John Inge Johnsen
Journal:  World J Exp Med       Date:  2015-02-20

4.  Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.

Authors:  Karel Zitterbart; Hana Filkova; Lenka Tomasikova; Eva Necesalova; Iva Zambo; Dagmar Kantorova; Iva Slamova; Vladimira Vranova; Dita Zezulkova; Martina Pesakova; Zdenek Pavelka; Renata Veselska; Petr Kuglik; Jaroslav Sterba
Journal:  J Neurooncol       Date:  2010-07-08       Impact factor: 4.130

5.  Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines.

Authors:  Marta Nekulová; Karel Zitterbart; Jaroslav Sterba; Renata Veselská
Journal:  J Mol Histol       Date:  2010-08-28       Impact factor: 2.611

6.  MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.

Authors:  Jakob Lovén; Nikolay Zinin; Therese Wahlström; Inga Müller; Petter Brodin; Erik Fredlund; Ulf Ribacke; Andor Pivarcsi; Sven Påhlman; Marie Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Authors:  Helena Gleissman; Rong Yang; Kimberly Martinod; Magnus Lindskog; Charles N Serhan; John Inge Johnsen; Per Kogner
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

8.  The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.

Authors:  Anna Djos; Tommy Martinsson; Per Kogner; Helena Carén
Journal:  Mol Cancer       Date:  2012-06-13       Impact factor: 27.401

9.  Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth.

Authors:  A Vilborg; C Bersani; M Wickström; L Segerström; P Kogner; K G Wiman
Journal:  Cell Death Dis       Date:  2012-04-19       Impact factor: 8.469

10.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.